For instance, RUNX1 mutations seem to be observed with a relatively frequent occurrence in leukemias with MPAL immunophenotype [12] leading to a discussion of whether a case should be classified as MPAL or AML with RUNX1 mutation (a provisional entity in WHO 2016). The gene discussed is RUNX1; the disease is mixed phenotype acute leukemia.